111 Inc (YI)
1.325
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
111 Profit Margin (Quarterly): -5.12% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -5.12% |
September 30, 2023 | -2.55% |
June 30, 2023 | -1.65% |
March 31, 2023 | -0.86% |
December 31, 2022 | -2.76% |
September 30, 2022 | -2.89% |
June 30, 2022 | -3.14% |
March 31, 2022 | -3.70% |
December 31, 2021 | -3.22% |
September 30, 2021 | -7.56% |
June 30, 2021 | -5.26% |
March 31, 2021 | -5.65% |
December 31, 2020 | -4.94% |
Date | Value |
---|---|
September 30, 2020 | -4.59% |
June 30, 2020 | -5.72% |
March 31, 2020 | -7.91% |
December 31, 2019 | -11.69% |
September 30, 2019 | -11.10% |
June 30, 2019 | -11.96% |
March 31, 2019 | -18.07% |
December 31, 2018 | -22.59% |
September 30, 2018 | -25.30% |
June 30, 2018 | -21.55% |
March 31, 2018 | -12.71% |
December 31, 2017 | -23.34% |
September 30, 2017 | -24.97% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-11.96%
Minimum
Jun 2019
-0.86%
Maximum
Mar 2023
-5.38%
Average
-4.94%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
Concord Medical Services Holdings Ltd | -- |
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | -279.5% |
Zai Lab Ltd | -61.36% |
ASLAN Pharmaceuticals Ltd | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -76.48% |
Return on Assets | -11.99% |
Return on Invested Capital | -48.82% |
Gross Profit Margin (Quarterly) | 5.21% |
Operating Margin (Quarterly) | -5.03% |
Return on Net Operating Assets | -16.69% |